Abstract:Ten patients undergoing surgical resection for spinal tumors were selected. Samples of tumor, muscle, and bone were resected, de-identified by the treating surgeon, and then scanned with the TumorID technology ex vivo. This study investigates whether TumorID technology is able to differentiate three different human clinical fresh tissue specimens: spine tumor, normal muscle, and normal bone. The TumorID technology utilizes a 405 nm excitation laser to target endogenous fluorophores, thereby allowing for the detection of tissue based on emission spectra. Metabolic profiles of tumor and healthy tissue vary, namely NADH (bound and free emission peak, respectively: 487 nm, 501 nm) and FAD (emission peak: 544) are endogenous fluorophores with distinct concentrations in tumor and healthy tissue. Emission spectra analyzed consisted of 74 scans of spine tumor, 150 scans of healthy normal bone, and 111 scans of healthy normal muscle. An excitation wavelength of 405 nm was used to obtain emission spectra from tissue as previously described. Emission spectra consisted of approximately 1400 wavelength intensity pairs between 450 and 750 nm. Kruskal–Wallis tests were conducted comparing AUC distributions for each treatment group, α = 0.05. Spectral signatures varied amongst the three different tissue types. All pairwise comparisons among tissues for Free NADH were statistically significant (Tumor vs. Muscle: p = 0.0006, Tumor vs. Bone: p < 0.0001, Bone vs. Muscle: p = 0.0357). The overall comparison of tissues for FAD (506.5–581.5 nm) was also statistically significant (p < 0.0001), with two pairwise comparisons being statistically significant (Tumor vs. Muscle: p < 0.0001, Tumor vs. Bone: p = 0.0045, Bone vs. Muscle: p = 0.249). These statistically significant differences were maintained when stratifying tumor into metastatic carcinoma (N = 57) and meningioma (N = 17). TumorID differentiates tumor tissue from normal bone and normal muscle providing further clinical evidence of its efficacy as a tissue identification tool. Future studies should evaluate TumorID's ability to serve as an adjunctive tool for intraoperative assessment of surgical margins and surgical decision-making.

Identification of tumor tissue in thin pathological samples via femtosecond laser-induced breakdown spectroscopy and machine learning

Preliminary fsLIBS study on bone tumors.

Signal enhancement with double-pulse LIBS on biological samples and better discrimination of tissues through machine learning algorithms

In-vitro study on the identification of gastrointestinal stromal tumor tissues using laser-induced breakdown spectroscopy with chemometric methods

Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast Tissue

In Vivo Time-Resolved Fluorescence Detection of Liver Cancer Supported by Machine Learning

Endomicroscopic AI-driven morphochemical imaging and fs-laser ablation for selective tumor identification and selective tissue removal

Machine learning approaches in non-contact autofluorescence spectrum classification

A robust tissue laser platform for analysis of formalin-fixed paraffin-embedded biopsies.

Discrimination of Melanoma Using Laser-Induced Breakdown Spectroscopy Conducted on Human Tissue Samples

Identification of Cervical Cancer Using Laser-Induced Breakdown Spectroscopy Coupled with Principal Component Analysis and Support Vector Machine.

A blinded study using laser induced endogenous fluorescence spectroscopy to differentiate ex vivo spine tumor, healthy muscle, and healthy bone

Accuracy Enhancement of Glioma Boundary Tissue Identification by Polarization-Resolved LIBS Spectral Fusion

Diagnosis of Human Malignancies Using Laser-Induced Breakdown Spectroscopy in Combination with Chemometric Methods

Laser Ablation Electrospray Ionization Time-of-Flight Mass Spectrometry for Direct Analysis of Biological Tissue

Subsecond lung cancer detection within a heterogeneous background of normal and benign tissue using single-point Raman spectroscopy

Tumor margin detection using optical biopsy techniques

Fluorescence-Guided Raman Spectroscopy for Tumour Margin Delineation

Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor‐Associated Immune Cell Signatures and Immuno Nano Sensors

Optimization of Machine Learning Classification Models for Tumor Cells Based on Cell Elements Heterogeneity with Laser-Induced Breakdown Spectroscopy.

Tissue Characterization in Some Clinical Specialities Utilizing Laser-Induced Fluorescence